Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2507 |  DBVT DBV Technologies S.A. - American Depositary Shares | 16.40 USD | -5.48% | +4.13% | +1.30% | +47.09% | 971.02 M USD | ||
| 2509 |  AVTX Avalo Therapeutics, Inc. - Common Stock | 18.39 USD | -4.47% | +2.57% | +42.23% | +273.78% | 966.68 M USD | ||
| 2510 |  JANX Janux Therapeutics, Inc. - Common Stock | 15.81 USD | -2.11% | +4.15% | +16.42% | -36.07% | 964.16 M USD | ||
| 2516 |  GERN Geron Corporation - Common Stock | 1.48 USD | -0.67% | +15.62% | +29.82% | +5.71% | 949.45 M USD | ||
| 2523 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 11.81 USD | +2.25% | +11.10% | +15.90% | +28.65% | 941.92 M USD | ||
| 2533 |  REPL Replimune Group, Inc. - Common Stock | 11.01 USD | -4.34% | -2.48% | +22.20% | +16.51% | 924.24 M USD | ||
| 2556 |  DSGN Design Therapeutics, Inc. - Common Stock | 14.44 USD | -1.84% | +3.81% | +35.84% | +288.17% | 901.88 M USD | ||
| 2570 |  TBPH Theravance Biopharma, Inc. - Ordinary Shares | 17.00 USD | -0.06% | 0.00% | +3.60% | +18.47% | 876.40 M USD | ||
| 2574 |  ZVRA Zevra Therapeutics, Inc. - Common Stock | 14.10 USD | -2.35% | -1.19% | +13.25% | +32.52% | 833.52 M USD | ||
| 2575 |  ANRO Alto Neuroscience, Inc. Common Stock | 24.77 USD | -3.69% | -2.98% | +25.86% | +890.80% | 869.28 M USD | ||
| 2597 |  PRME Prime Medicine, Inc. - Common Stock | 4.57 USD | +14.54% | +18.09% | +52.84% | +9.33% | 825.42 M USD | ||
| 2600 |  IVA Inventiva S.A. - American Depository Shares | 4.26 USD | -6.58% | +18.33% | +6.50% | +24.93% | 823.19 M USD | ||
| 2618 |  RGNX REGENXBIO Inc. - Common Stock | 14.93 USD | -0.60% | +12.09% | +139.65% | +11.17% | 771.85 M USD | ||
| 2627 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.66 USD | -4.69% | -0.27% | +22.41% | +51.87% | 796.79 M USD | ||
| 2630 |  SPRY ARS Pharmaceuticals, Inc. - Common Stock | 7.75 USD | -5.37% | -5.37% | -14.08% | -15.85% | 769.60 M USD | ||
| 2632 |  CLYM Climb Bio, Inc. - Common Stock | 13.14 USD | -2.09% | -1.20% | +21.89% | +140.22% | 752.40 M USD | ||
| 2642 |  RIGL Rigel Pharmaceuticals, Inc. - Common Stock | 42.11 USD | -1.06% | +8.09% | +38.61% | +39.76% | 779.12 M USD | ||
| 2663 |  OMER Omeros Corporation - Common Stock | 10.29 USD | -0.39% | +7.52% | +4.36% | +226.67% | 744.74 M USD | ||
| 2667 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 8.49 USD | +2.41% | +5.99% | +6.13% | -10.54% | 680.11 M USD | ||
| 2677 |  PTCT PTC Therapeutics, Inc. - Common Stock | 88.36 USD | -0.94% | +7.99% | +20.81% | +82.75% | 732.94 M USD |
Nouvelles Biotechnology Stocks
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
 ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
 APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
 TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
 TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
 ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |